Earnings summaries and quarterly performance for Alignment Healthcare.
Executive leadership at Alignment Healthcare.
John Kao
Chief Executive Officer
Andreas Wagner
Chief Human Resources Officer
Christopher Joyce
Chief Legal & Administrative Officer
Dawn Maroney
President
Jim Head
Chief Financial Officer
Ken Kim
Chief Medical Officer
Robert Scavo
Chief Information Officer
Sebastian Burzacchi
Chief Operating Officer – Management Services Organization
Board of directors at Alignment Healthcare.
Research analysts who have asked questions during Alignment Healthcare earnings calls.
Andrew Mok
Barclays
4 questions for ALHC
Jessica Tassan
Piper Sandler
4 questions for ALHC
Michael Ha
Robert W. Baird & Co.
4 questions for ALHC
John Ransom
Raymond James
3 questions for ALHC
Matthew Gillmor
KeyCorp
3 questions for ALHC
Whit Mayo
Leerink Partners
3 questions for ALHC
Adam Ron
Bank of America Corporation
2 questions for ALHC
Craig Jones
Stifel Financial Corp.
2 questions for ALHC
Jonathan Yong
UBS
2 questions for ALHC
Ryan Daniels
William Blair & Company, L.L.C.
2 questions for ALHC
Ryan Langston
TD Cowen
2 questions for ALHC
Jared Haase
William Blair & Company
1 question for ALHC
Joanna Gajuk
Bank of America
1 question for ALHC
John Stansel
JPMorgan Chase & Co.
1 question for ALHC
Matthew Gilmore
KeyBanc Capital Markets
1 question for ALHC
Scott Fidel
Stephens Inc.
1 question for ALHC
Recent press releases and 8-K filings for ALHC.
- Alignment Healthcare has achieved significant growth, reaching over 275,000 members and guiding to nearly 300,000 by year-end, with premium revenue approaching $4 billion and a 30% annual growth rate over the last decade.
- The company's care management model enables strong growth while improving Medical Loss Ratios (MLR), demonstrated by 58% growth in 2024 and 31% growth in Q1 2025, where MLR decreased. All members are in four-star and above plans, including three five-star plans.
- Alignment Healthcare is expanding geographically, with 84% growth outside California, where gross profit per member per month (PMPM), Star Ratings, and utilization management metrics are better. The company plans to invest in new markets starting in 2027.
- The company reaffirmed its 2025 guidance for mid-to-high 90s MLR and expects $145 million in Adjusted EBITDA for 2026. Management anticipates continued growth and margin expansion, projecting $7 billion to $8 billion in revenue within three years.
- Alignment HealthCare reported 275,300 total members as of Jan. 1, 2026, reflecting 31% year-over-year growth from 209,900 members on Jan. 1, 2025. The company provides a year-end 2026 membership guidance range of 290,000 to 296,000.
- The company projects a profitability inflection in 2025 with an adjusted EBITDA guidance raised to $94 million at the midpoint, and expects consensus adjusted EBITDA of $145 million for FY 2026. Total revenue is projected at $3,939 million for both 2025G and 2026G.
- 100% of Alignment's members are in plans rated 4 stars or above for the 2025 and 2026 payment years, supported by a 19% improvement in voluntary disenrollment from 7.9% in 2025 to 6.4% in 2026.
- ALHC plans to invest in new market infrastructure in 2026 and launch new markets in 2027, leveraging internally generated cash flows to expand its footprint beyond its current 275,300 members across 45 counties and 5 states.
- Alignment Healthcare reported robust growth, with over 275,000 members and guided to nearly 300,000 by year-end, approaching $4 billion in premium revenue on a guidance basis, and consistently growing at 30% per year. The company achieved 58% growth in 2024 and 31% in Q1 (through Q3 data).
- The company attributes its performance to a care management model that stratifies members and deploys "Care Anywhere" teams, resulting in improved retention and 80% of growth from switchers. This model also leads to better gross profit PMPMs and Star Ratings outside of California.
- The CFO reaffirmed 2025 guidance (mid-to-high 90s, mid-2s margin) and provided preliminary 2026 guidance of $145 million in Adjusted EBITDA. Management projects $7 billion to $8 billion in revenue within three years (assuming 20% annual growth) and plans to invest in new markets starting in 2027.
- Alignment Healthcare reported significant growth, reaching over 275,000 members and approaching $4 billion in premium revenue, with a historical annual growth rate of 30%. The company achieved 58% growth in 2024 and 31% in Q1 2025, with data available through Q3 2025, while maintaining a stable Medical Benefit Ratio (MBR).
- The company affirmed its 2025 guidance for a mid-to-high 90s MBR and provided preliminary 2026 guidance for $145 million in Adjusted EBITDA.
- Alignment Healthcare plans to expand into new markets starting in 2027, with a long-term goal to scale from approximately 300,000 to 3 million members and projects $7 billion to $8 billion in revenue within three years with margin expansion.
- The company attributes its success to its care management model, resulting in 100% of members in four-star and above plans, and anticipates improved conditions for the Medicare Advantage sector starting in 2027 due to favorable benchmark rates and the conclusion of V28 phase-in.
- Alignment Healthcare reported 31% year-over-year membership growth, reaching approximately 275,300 members as of January 1, 2026.
- The company provided a year-end 2026 health plan membership guidance range of 290,000 to 296,000 and expects consensus adjusted EBITDA of approximately $145 million in 2026 to be within its full-year guidance range.
- Alignment Healthcare reaffirmed its full-year 2025 guidance, including health plan membership of 232,500 to 234,500, revenue of $3,931 million to $3,946 million, adjusted gross profit of $474 million to $483 million, and adjusted EBITDA of $90 million to $98 million.
- Alignment Healthcare announced Jan. 1, 2026, health plan membership of approximately 275,300, representing 31% year-over-year growth.
- The company provided year-end 2026 health plan membership guidance of 290,000 to 296,000.
- Alignment Healthcare anticipates consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year guidance range.
- The company reaffirmed its full-year 2025 guidance for health plan membership, revenue, adjusted gross profit, and adjusted EBITDA.
- Alignment Healthcare (ALHC) projects 2026 membership growth between 20% and 30%, potentially exceeding 30% due to better-than-expected retention, following 60% growth in 2024 and high 20% growth in 2025.
- The company's 2026 Medicare Advantage bids were optimized for a balance between growth and margin, a shift from 2025 bids which prioritized margin.
- ALHC expects membership outside California to double in 2026 from approximately 35,000 members in 2025, while the overall MA market is anticipated to be relatively flat.
- Operational improvements, including the maturation of the 2024 member cohort and de-delegation of certain IPA functions, are driving margin expansion and improved clinical outcomes, with new member MLRs improving from 90% at enrollment to the low 80s over time.
- For 2027 Stars, the potential elimination of the Health Equity Index (HEI) reward factor is seen as a loss of a "tailwind" that could make achieving 4.5 stars more challenging, though 4-star performance is not predicated on it.
- Alignment Healthcare projects 2026 membership growth between 20% and 30%, potentially exceeding 30% due to strong retention, building on 60% growth in 2024 and high 20s% in 2025.
- The company is expanding margins by 250 basis points in 2025 and designed its 2026 bids for a balanced approach between growth and margin, after favoring margin in 2025 and growth in 2024.
- Alignment expects to double its ex-California membership in 2026 from approximately 35,000 members in 2025, with strong performance in new markets.
- The company anticipates the overall Medicare Advantage market to be relatively flat in 2026 and notes that the elimination of the Health Equity Index (HEI) reward factor for 2027 would remove a tailwind for achieving four and a half stars, though it would not compromise its ability to hit four stars.
- Alignment Healthcare expects 20%-30% membership growth in 2026, potentially exceeding 30% due to better-than-expected retention rates, following 60% growth in 2024 and high 20s% in 2025.
- The company is expanding margins by 250 basis points in 2025.
- For 2026, Alignment optimized its Medicare Advantage bids for a balanced approach between growth and margin, contrasting with a growth-focused 2024 and margin-focused 2025.
- Investments in infrastructure and clinical efficacy, including a transition care program, are expected to improve MLR efficacy and member satisfaction, with all clinical programs anticipated to be deployed in 2026.
- While the overall Medicare Advantage market is expected to be relatively flat in 2026, Alignment anticipates doubling its ex-California membership from approximately 35,000 members in 2025.
- Alignment Healthcare (ALHC) anticipates 20-30% membership growth in 2026, potentially exceeding 30% due to better-than-expected retention rates, following 46% growth in 2025.
- The company's 2025 bids prioritized margin, while 2026 bids were more balanced between growth and margin, with an expectation of expanding margins by 50 basis points in 2025.
- ALHC is enhancing its care delivery model by de-delegating certain functions from IPAs in California, which has resulted in lower admissions per thousand, and plans to fully deploy a transition of care program in 2026 to further improve MLR efficacy.
- For 2027, the proposed removal of the Health Equity Index (HEI) reward factor for star ratings is viewed as a loss of a tailwind for ALHC, potentially impacting its ability to achieve 4.5 stars but not its 4-star performance.
Quarterly earnings call transcripts for Alignment Healthcare.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more